Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» China
China
Biden likely to sign a bill that would crack down on China's chokehold on the antibiotic supply
Endpoints
Wed, 03/30/22 - 10:59 am
Senate
legislation
China
antibiotics
Joe Biden
Another strike for biotech: China
EP Vantage
Mon, 03/14/22 - 10:18 am
biotech
China
foreign inspections
Innovent's phase 3 hits tee it up to challenge Amgen and Sanofi for Chinese PCSK9 market
Fierce Biotech
Thu, 02/17/22 - 10:56 am
Innovent Biologics
China
clinical trials
Amgen
Sanofi
FDA sends signal with tough questions of Lilly at cancer drug meeting
BioPharma Dive
Thu, 02/10/22 - 10:37 pm
Eli Lilly
Innovent Biologics
lung cancer
clinical trials
China
China-Developed Drugs for U.S. Market Could Face Steep Hill
BioSpace
Wed, 02/9/22 - 11:01 am
China
drug approvals
FDA
clinical trials
AstraZeneca reveals insurance fraud probe in China as officials say they've made criminal arrests
Fierce Pharma
Mon, 01/31/22 - 10:43 am
AstraZeneca
China
fraud
insurance
Clover Biopharmaceuticals sets up a new R&D center in a buzzy Chinese hub near Shanghai
Endpoints
Wed, 01/5/22 - 10:44 pm
Clover BioPharmaceuticals
China
R&D
Abandoned by Amgen, Cytokinetics lands $50M upfront deal for Chinese rights to heart failure prospect
Fierce Biotech
Tue, 12/21/21 - 10:34 am
Cytokinetics
heart failure
Omecamtiv Mecarbil
Amgen
China
Ji Xing Pharmaceuticals
Novartis Deepens BeiGene Oncology Pact, Posts Disappointing Results in CSU
BioSpace
Mon, 12/20/21 - 10:49 am
Novartis
BeiGene
China
ociperlimab
anti-TIGIT
Connect Biopharma celebrates a mid-stage win for its Dupixent rival, but shares tank after investors clamor for data
Endpoints
Fri, 12/17/21 - 10:52 am
Connect Biopharma
Dupixent
China
eczema
clinical trials
Biotech BeiGene slides in Shanghai after $3.5 bln STAR debut
Yahoo/Reuters
Wed, 12/15/21 - 10:39 am
BeiGene
STAR market
China
Shanghai
Eli Lilly pens $1.5B biobucks pact with China's Regor for metabolic disease work
Fierce Biotech
Fri, 12/10/21 - 11:05 am
Eli Lilly
China
Regor Therapeutics
metabolic disorders
Drugmakers cut prices on average by more than 60% to get on China's 2022 NDRL list — report
Endpoints
Fri, 12/3/21 - 10:37 am
China
drug pricing
NRDL
After Big Pharma sparked interest in the US, Ablaze looks to bring radiopharmaceuticals overseas
Endpoints
Tue, 11/30/21 - 10:26 am
Ablaze Pharmaceuticals
funding
RayzeBio
China
radiopharmaceuticals
TRTs
Novo Nordisk, Sanofi and Eli Lilly cut insulin prices and lose share in China's latest cost squeeze
Fierce Pharma
Mon, 11/29/21 - 10:55 pm
Novo Nordisk
Sanofi
Eli Lilly
insulin
China
diabetes
drug pricing
China’s insulin plans will hit 2022 revenues, says Novo Nordisk
Pharmaforum
Fri, 11/26/21 - 08:54 pm
Novo Nordisk
China
insulin
diabetes
value-based procurement
Connect Biopharma celebrates a mid-stage win for its Dupixent rival, but shares tank after investors clamor for data
Endpoints
Fri, 11/19/21 - 11:10 am
Connect Biopharma
China
eczema
clinical trials
CBP-201
Dupixent
Signet Therapeutics gets a $10M top-up for next-gen cancer bets
Fierce Biotech
Fri, 10/29/21 - 11:07 am
Signet Therapeutics
funding
venture capital
China
cancer
oncology
Pfizer drones light up night sky in China's remote area with health tips
Fierce Pharma
Fri, 10/29/21 - 10:37 am
Pfizer
drones
China
pharma marketing
Juventas Cell Therapy closes a $63M funding round as it eyes a big push for blood cancer hopeful
Fierce Biotech
Mon, 10/25/21 - 10:53 am
Juventas Cell THerapy
funding
CNCT19
China
CASI Pharmaceuticals
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »